Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
J Cell Physiol ; 207(3): 614-27, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16523487

RESUMEN

It has been proposed that the enhanced metabolic activity of tumor cells is accompanied by an increased expression of facilitative hexose transporters (GLUTs). However, a previous immunohistochemical analysis of GLUT1 expression in 154 malignant human neoplasms failed to detect the GLUT1 isoform in 87 tumors. We used 146 normal human tissues and 215 tumor samples to reassess GLUT1 expression. A similar number of samples were used to compare the expression of GLUT2-6 and 9. The classical expression of GLUT1-5 in different normal human tissues was confirmed, however, we were unable to detect GLUT2 in human pancreatic islet cells. GLUT6 was principally detected in testis germinal cells and GLUT9 was localized in kidney, liver, heart, and adrenal. In tumor samples, GLUT1, 2, and 5 were the main transporters detected. GLUT1 was the most widely expressed transporter, however, 42% of the samples had very low-to-negative expression levels. GLUT2 was detected in 31% of the samples, being mainly expressed in breast, colon, and liver carcinoma. GLUT5 was detected in 27% of breast and colon adenocarcinoma, liver carcinoma, lymphomas, and testis seminoma samples. In situ RT-PCR and ultrastructural immunohistochemistry confirmed GLUT5 expression in breast cancer. GLUT6 and 9 are not clearly over-expressed in human cancer. The extensive expression of GLUT2 and 5 (glucose/fructose and fructose transporters, respectively) in malignant human tissues indicates that fructose may be a good energy substrate in tumor cells. Our functional data obtained in vitro in different tumor cells support this hypothesis. Additionally, these results suggest that fructose uptake could be used for positron emission tomography imaging and, may possibly represent a novel target for the development of therapeutic agents in different human cancers.


Asunto(s)
Mama/metabolismo , Mama/patología , Proteínas Facilitadoras del Transporte de la Glucosa/metabolismo , Neoplasias/metabolismo , Neoplasias/patología , Animales , Biopsia , Mama/ultraestructura , Regulación Neoplásica de la Expresión Génica , Proteínas Facilitadoras del Transporte de la Glucosa/genética , Salud , Humanos , Inmunohistoquímica , Hibridación in Situ , Ratones , Microscopía Inmunoelectrónica , Neoplasias/genética , Neoplasias/ultraestructura , Especificidad de Órganos , Ratas , Células Tumorales Cultivadas
2.
Rev Med Chil ; 131(4): 432-5, 2003 Apr.
Artículo en Español | MEDLINE | ID: mdl-12870239

RESUMEN

Parathyroid cysts are unusual and do not have specific clinical manifestations or ultrasonographic findings. Therefore, they are usually confused with thyroid nodules. We report a 43 years old male, with normal thyroid function and normal calcium serum levels, that presented a nodule in the lower right third of the neck. Ultrasonography and CAT scan showed a well delimited 6 x 4.5 cm ovoid cyst that compressed and displaced the trachea and esophagus. A fine needle aspiration was done on three occasions, extracting 18, 40 and 60 ml of liquid. As the cyst recurred and symptoms intensified, the patient was operated removing the cyst and the right thyroid lobe. Pathological study disclosed a parathyroid cyst.


Asunto(s)
Quistes/patología , Enfermedades de las Paratiroides/patología , Adulto , Biopsia con Aguja , Quistes/diagnóstico por imagen , Quistes/cirugía , Humanos , Masculino , Enfermedades de las Paratiroides/diagnóstico por imagen , Enfermedades de las Paratiroides/cirugía , Glándulas Paratiroides/patología , Tomografía Computarizada por Rayos X , Ultrasonografía
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda